Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate

Prostate

Volumn 31, Issue 4, 1997, Pages 223-233

  Cronauer, Marcus V ^a   Hittmair, Anton ^b   Eder, Iris E ^a   Hobisch, Alfred ^a   Culig, Zoran ^a   Ramoner, Reinhold ^a   Zhang, Ju ^a   Bartsch, Georg ^a   Reissigl, Andreas ^a   Radmayr, Christian ^a   Thurnher, Martin ^a   Klocker, Helmut ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

bFGF; bFGF serum levels; Immunohistochemistry; Prostatic cancer cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; GROWTH REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030981432     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970601)31:4<223::AID-PROS3>3.0.CO;2-L     Document Type: Article

References (55)

1. Isaacs JT: Introduction: Survey of outstanding problems in the management of prostatic cancer. In Isaacs JT (ed): "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment," New York: Cold Spring Harbor Laboratory Press, 1991: 1-3.
2. Mansson P-E, Adams P, Kan M, McKeehan WL: Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res 49:2485-2494, 1989.
3. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522, 1993.
4. Begun FP, Story MT, Hopp KA, Shapiro E, Lawson RK: Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates. J Urol 153:839-843, 1995.
5. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida D, Hatanaka M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type 2 in human benign hyperplasia. Prostate 16:71-80, 1990.
6. Nakamoto T, Chang C, Li A, Chodak GW: Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 52: 571-577, 1992.
7. Story MT: Regulation of prostate growth by fibroblast growth factor. World J Urol 13:297-305, 1995.
8. Moscatelli D, Presta M, Joseph-Silverstein J, Rifkin DB: Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol 129:273-276, 1986.
9. Jacobs SC, Story MT, Sasse J, Lawson RK: Characterization of growth factors derived from the rat ventral prostate. J Urol 139: 1106-1110, 1988.
10. Story MT, Livingston B, Baeten L, Swartz SJ, Jacobs SC, Begun FP, Lawson RK: Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 15:355-365, 1989.
11. Sherwood ER, Fong CJ, Lee C, Kozlowski JM: Basic fibroblast growth factor: A potential mediator of stromal growth in the human prostate. Endocrinology 130:2955-2963, 1992.
12. Marengo SR, Chung LWK: An orthotropic model for the study of growth factors in the ventral prostate of the rat: Effects of epidermal growth factor and basic fibroblast growth factor. J Androl 15:277-286, 1994.
13. Burges WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606, 1989.
14. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodawsky I: A heparin binding angiogenic protein-basic fibroblast growth factor is stored within the basement membrane. Am J Pathol 130:393-400, 1988.
15. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301, 1986.
16. Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442-447, 1987.
17. Ishihara M, Shaklee PN, Yang Z, Liang W, Wei Z, Stack RJ, Holme K: Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor. Glycobiology 4:451-458, 1994.
18. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1992.
19. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991.
20. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993.
21. Bigler SA, Deering RE, Brawer MK: A quantitative morphometric analysis of the microcirculation in prostate carcinoma. Hum Pathol 24:220-226, 1993.
22. Deering RE, Bigler SA, Brown M, Brawer MK: Microvascularity in benign prostatic hyperplasia. Prostate 26:111-115, 1995.
23. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73:678-687, 1994.
24. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23, 1979.
25. Stone KR, Mickey DH, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21:274-281, 1978.
26. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818, 1983.
27. Aulitzky W, Frick J, Fuchs D, Hausen A, Reibnegger G, Wachter H: Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract. Cancer 55:1052-1055, 1985.
28. Lewenhaupt A, Ekman P, Eneroth P, Nilsson B: Tumor markers as prognostic aids in prostatic carcinoma. Br J Urol 66:182-187, 1990.
29. Samsonov MV, Tilz GP, Pisklakov VP, Reibnegger G, Nassonov EL, Nassonova VA, Wachter H, Fuchs D: Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 74:31-34, 1995.
30. Mostofi FK, Sesterhenn IA, Sobin LH: "Histological Typing of Prostate Tumors." Geneva, Switzerland: WHO Monograph Series No. 22, 1980.
31. Schmidt A, Skaletz-Rorowski A, Breithardt G, Buddecke E: Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells. Eur J Cell Biol 67:130-134, 1995.
32. Schmidt A, Skaletz-Rorowski A, Buddecke E: Basic fibroblast growth factor controls the expression and molecular structure of heparan sulfate in corneal endothelial cells. Eur J Biochem 234: 479-484, 1995.
33. Gospadarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484, 1986.
34. Meyer GE, Yu E, Siegal JA, Petteway JC, Blumenstein BA, Brawer MK: Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76:2304-2311, 1995.
35. Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett 94:227-231, 1995.
36. O'Brien TS, Smith K, Cranston D, Fuggle S, Sickness R, Harris AL: Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol 76:311-314, 1995.
37. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G: DNA sequence of the androgen receptor in prostatic rumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22:11-22, 1993.
38. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H: Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1550, 1993.
39. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT: Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25: 249-265, 1994.
40. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study. J Pathol 168:257-262, 1992.
41. Bigler SA, Deering RE, Brawer MK: Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24:220-226, 1993.
42. Cleave ME, Hsieh JT, von Eschenbach AC, Chung LWK: Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147: 1151-1159, 1992.
43. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor, a protein devoid of a signal sequence, is released by cells via a pathway independent of endoplasmatic reticulum-Golgi complex. J Cell Physiol 151:81-83, 1992.
44. Baird A, Ling N: Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142:428-435, 1987.
45. Vlodawsky I, Bar-Shavit R, Isahai-Michaeli R, Bashkin P, Fuks Z: Extracellular sequestration and release of fibroblast growth factor: A regulatory mechanism? TIBS 16:268-271, 1991.
46. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H: Immunohistochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68:520-527, 1993.
47. Friess H, Yamanaka Y, Buchler M, Berger HG, Do DA, Kobrin MS, Korc M: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 144:117-128, 1994.
48. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion JJ, Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. JNCI 84:951-957, 1992.
49. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP: Transplantation of human prostatic carcinoma into nude mice in matrigel. Cancer Res 51:3814-3817, 1991.
50. Story MT: Polypeptide modulators of prostatic growth and development. In Isaacs JT (ed): "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment," New York: Cold Spring Harbor Laboratory Press, 1991:123-146.
51. Yamanaka Y, Friess H, Buchler M, Berger HG, Uchida E, Onda M, Kobrin MS, Korc M: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53:5289-5296, 1993.
52. Soutter AD, Nguyen M, Watanabe H, Folkman J: Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 53:5297-5299, 1993.
53. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun MT: Lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 91:2890-2894, 1994.
54. Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ: T lymphocytes that infiltrate tumors and artherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: A potential pathologic role. Proc Natl Acad Sci USA 92:6547-6551, 1995.
55. McCarty LP III, Karr SM, Harris BZ, Michelson SG, Leith JT: Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumors. Br J Urol 72:10-16, 1995.